COVID-19, from infection to cancer

Main Article Content

Mohanna Khandan
Mohammad Amin Khazeei Tabari
Noosha Samieefar
Nima Rezaei


COVID-19, SARS-CoV-2, Cancer, Tumor markers


Download data is not yet available.
Abstract 72 | PDF Downloads 42


(1) Tabari MAK, Khoshhal H, Tafazoli A, Khandan M, Bagheri A. Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic. Informatics in Medicine Unlocked. 2020;21:100458.
(2) Nepogodiev D, Bhangu A, Glasbey JC, Li E, Omar OM, Simoes JFF, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. The Lancet. 2020;396(10243):27-38.
(3) Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. The American journal of emergency medicine. 2020;38(7):1504-7.
(4) Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. The Lancet Neurology. 2020.
(5) Jyotsana N, King MR. The impact of COVID-19 on cancer risk and treatment. Cellular and Molecular Bioengineering. 2020:1-7.
(6) Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nature reviews Disease primers. 2019;5(1):1-21.
(7) Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 2020;395(10224):575-90.
(8) Purut YE, Giray B, Gurbuz E. Effect of the coronavirus pandemic on tumor markers. Journal of Medical Virology. 2021.
(9) Garg A, Seeliger B, Derda AA, Xiao K, Gietz A, Scherf K, et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. European journal of heart failure. 2021;23(3):468-75.
(10) Francescangeli F, De Angelis ML, Zeuner A. COVID-19: a potential driver of immune-mediated breast cancer recurrence? Breast Cancer Research. 2020;22(1):117.
(11) Yang J, Li H, Hu S, Zhou Y. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19. Aging. 2020;12(8):6518-35.

Most read articles by the same author(s)

1 2 > >>